text
"['\n4. 재무제표\n(1) 재무상태표\n\xa0 \xa0\xa0 재\xa0\xa0 무\xa0\xa0 상\xa0\xa0 태\xa0\xa0 표\n제 65 기 2분기 :\xa0 2020년 06월 30일 현재\n제 64 기\xa0 \xa0 \xa0 \xa0\xa0 :\xa0 2019년 12월 31일 현재\n제 63 기\xa0 \xa0 \xa0 \xa0\xa0 :\xa0 2018년 12월 31일 현재\n삼성생명보험주식회사\n(단위 : 백만원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 목\n제 65 (당) 2분기\n제 64(전) 기\n제 63 (전전) 기\nⅠ.현금및현금성자산\n1,131,073\n4,395,740\n2,095,482\nⅡ.당기손익인식금융자산\n4,612,487\n1,179,900\n1,359,641\nⅢ.매도가능금융자산\n166,783,855\n165,245,105\n146,465,724\nⅣ.만기보유금융자산\n244,102\n244,382\n244,953\nV.대출채권및기타수취채권\n49,625,932\n49,651,230\n49,303,326\nⅥ.위험회피목적파생상품자산\n441,586\n496,398\n672,758\nⅦ.관계ㆍ종속기업투자\n8,742,013\n8,361,987\n8,364,366\nⅧ.매각예정자산\n-\n98,637\n-\nIX.투자부동산\n3,415,597\n3,437,243\n3,712,839\nX.유형자산\n682,143\n693,191\n764,034\nXI.무형자산\n361,672\n390,937\n445,642\nXII.사용권자산\n154,998\n144,973\n-\nXIII.당기법인세자산\n1,940\n526,538\n-\nXⅣ.기타자산\n2,724,086\n2,696,324\n2,867,835\nXV.특별계정자산\n52,409,435\n49,795,298\n45,933,890\n자\xa0 \xa0 \xa0\xa0 산\xa0 \xa0 \xa0\xa0 총\xa0 \xa0 \xa0\xa0 계\n291,330,919===============\n287,357,883===============\n262,230,490===============\nⅠ.보험계약부채\n184,320,783\n180,045,562\n173,617,774\nⅡ.계약자지분조정\n11,458,488\n11,504,045\n8,177,256\nⅢ.당기손익인식금융부채\n182,905\n100,773\n8,122\nⅣ.기타금융부채\n1,208,543\n1,068,826\n987,338\nⅤ.위험회피목적파생상품부채\n669,460\n328,590\n125,711\nⅥ.당기법인세부채\n-\n-\n248,001\nⅦ.이연법인세부채\n7,305,647\n7,477,583\n4,976,033\nⅧ.충당부채\n106,915\n92,976\n150,356\nⅨ.기타부채\n377,436\n293,724\n297,706\nX.특별계정부채\n52,534,742\n53,360,255\n47,143,714\n부\xa0 \xa0 \xa0\xa0 채\xa0 \xa0 \xa0\xa0 총\xa0 \xa0 \xa0\xa0 계\n258,164,919\n254,272,334\n235,732,011\nⅠ.자본금\n100,000\n100,000\n100,000\nⅡ.자본잉여금\n6,131\n6,131\n6,131\nⅢ.자본조정\n(2,110,369)\n(2,110,369)\n(2,110,369)\nⅣ.기타포괄손익누계액\n21,509,250\n21,570,927\n15,341,789\nⅤ.이익잉여금\n13,660,988\n13,518,860\n13,160,928\n자\xa0 \xa0 \xa0\xa0 본\xa0 \xa0 \xa0\xa0 총\xa0 \xa0 \xa0\xa0 계\n33,166,000\n33,085,549\n26,498,479\n부\xa0\xa0 채\xa0\xa0 와\xa0\xa0 자\xa0\xa0 본\xa0\xa0 총\xa0\xa0 계\n291,330,919================\n287,357,883================\n262,230,490================\n(2) 포괄손익계산서\n반\xa0\xa0 기\xa0\xa0 포\xa0\xa0 괄\xa0\xa0 손\xa0\xa0 익\xa0\xa0 계\xa0\xa0 산\xa0\xa0 서\n제65기 2분기 :\xa0 2020년 01월 01일부터 2020년 06월 30일까지\n제64기 2분기 :\xa0 2019년 01월 01일부터 2019년 06월 30일까지\n제64기\xa0 :\xa0 2019년 01월 01일부터 2019년 12월 31일까지\n제63기\xa0 :\xa0 2018년 01월 01일부터 2018년 12월 31일까지\n삼성생명보험주식회사\n(단위 : 백만원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 목\n제 65 (당) 기 2분기\n제 64 (전) 기 2분기\n제 64 (전) 기\n제 63 (전전) 기\nⅠ.영업수익\n15,587,836\n13,941,831\xa0\n27,091,805\n27,849,200\xa0\n\xa0 1.보험료수익\n8,477,721\n7,989,807\xa0\n16,046,759\n16,000,954\xa0\n\xa0 2.재보험수익\n180,530\n164,623\xa0\n389,151\n340,052\xa0\n\xa0 3.이자수익\n2,756,749\n2,838,271\xa0\n5,691,667\n5,674,229\xa0\n\xa0 4.당기손익인식금융자산관련이익\n921,298\n297,898\xa0\n434,680\n370,246\xa0\n\xa0 5.매도가능금융자산관련이익\n397,125\n119,612\xa0\n271,231\n1,244,821\xa0\n\xa0 6.위험회피목적파생상품관련이익\n126,055\n17,332\xa0\n68,882\n193,052\xa0\n\xa0 7.외환거래이익\n667,313\n593,600\xa0\n619,002\n469,873\xa0\n\xa0 8.수수료수익\n11,779\n8,871\xa0\n20,425\n19,472\xa0\n\xa0 9.배당금수익\n502,402\n543,798\xa0\n964,333\n969,826\xa0\n\xa0 10.임대료수익\n118,143\n128,907\xa0\n256,649\n256,412\xa0\n\xa0 11.특별계정수입수수료\n797,639\n824,846\xa0\n1,626,473\n1,653,367\xa0\n\xa0 12.특별계정수익\n403,214\n271,521\xa0\n523,644\n478,535\xa0\n\xa0 13.기타영업수익\n227,868\n142,745\xa0\n178,909\n178,361\xa0\n\u3000\n\u3000\n\u3000\nⅡ.영업비용\n15,048,878\n13,431,391\xa0\n26,568,013\n25,859,703\xa0\n\xa0 1.보험계약부채전입액\n4,005,212\n2,802,825\xa0\n5,924,988\n6,377,603\xa0\n\xa0 2.지급보험금\n7,030,095\n7,252,588\xa0\n14,426,913\n13,478,413\xa0\n\xa0 3.재보험비용\n245,243\n214,733\xa0\n442,779\n388,880\xa0\n\xa0 4.사업비\n985,281\n1,098,507\xa0\n2,119,192\n2,188,991\xa0\n\xa0 5.신계약비상각비\n642,157\n735,140\xa0\n1,441,454\n1,556,301\xa0\n\xa0 6.재산관리비\n165,881\n176,449\xa0\n351,795\n387,911\xa0\n\xa0 7.이자비용\n10,163\n9,493\xa0\n20,412\n14,237\xa0\n\xa0 8.당기손익인식금융자산관련손실\n499,313\n117,591\xa0\n295,585\n65,933\xa0\n\xa0 9.매도가능금융자산관련손실\n135,044\n31,459\xa0\n58,619\n12,710\xa0\n\xa0 10.대출채권및기타수취채권관련손실\n28,296\n19,639\xa0\n43,138\n15,618\xa0\n\xa0 11.위험회피목적파생상품관련손실\n645,377\n568,549\xa0\n625,671\n478,443\xa0\n\xa0 12.외환거래손실\n104,868\n29,284\xa0\n81,404\n183,003\xa0\n\xa0 13.특별계정비용\n403,214\n271,521\xa0\n523,644\n478,535\xa0\n\xa0 14.기타영업비용\n148,734\n103,613\xa0\n212,419\n233,125\xa0\n\u3000\n\u3000\n\u3000\nⅢ. 영업이익\n538,958\n510,440\xa0\n523,792\xa0\n1,989,497\xa0\n\u3000\n\u3000\n\u3000\nⅣ.영업외수익\n246,363\n306,454\xa0\n545,968\xa0\n481,748\xa0\n\u3000\n\u3000\n\u3000\nⅤ.영업외비용\n32,163\n14,843\xa0\n56,216\xa0\n135,617\xa0\n\u3000\n\u3000\n\u3000\nⅥ.법인세비용차감전순이익\n753,158\n802,051\xa0\n1,013,544\xa0\n2,335,628\xa0\n\u3000\n\u3000\n\u3000\nⅦ.법인세비용\n135,157\n145,382\xa0\n179,739\xa0\n537,854\xa0\n\u3000\n\u3000\n\u3000\nⅧ.당반기순이익\n618,001\n656,669\xa0\n833,805\xa0\n1,797,774\xa0\n\u3000\n\u3000\n\u3000\nⅨ.법인세비용차감후기타포괄손익\n(61,677)\n4,857,008\xa0\n6,229,138\n(1,758,848)\n\xa0 1.후속적으로 당기손익으로 재분류될 수 있는 포괄손익\n\xa0\xa0 가.매도가능금융자산평가손익\n(126,665)\n4,710,265\xa0\n6,157,982\n(2,005,873)\n\xa0\xa0 나.만기보유금융자산평가손익\n-\n-\xa0\n-\n(15)\n\xa0\xa0 다.위험회피목적파생상품평가손익\n(3,731)\n17,823\xa0\n(18,809)\n244,937\xa0\n\xa0\xa0 라.관계ㆍ종속기업기타포괄손익지분\n11,591\n27,719\xa0\n5,415\n(30,735)\n\xa0\xa0 마.특별계정기타포괄손익\n58,804\n102,137\xa0\n97,423\n45,543\xa0\n\xa0 2.당기손익으로 재분류되지 않는 포괄손익\n\xa0\xa0 가.순확정급여부채 재측정요소\n(1,676)\n(936)\n(12,873)\n(12,705)\n\u3000\n\u3000\n\u3000\nX.당반기총포괄이익\n556,324\n5,513,677\xa0\n7,062,943\xa0\n38,926\xa0\n\u3000\n\u3000\n\u3000\nXI.주당이익(단위: 원)\xa0\n\u3000\n\u3000\n\u3000\n\xa0\xa0 기본주당이익\n3,441\n3,657\xa0\n4,643\n10,011\xa0\n\xa0\xa0 희석주당이익\n3,441\n3,657\xa0\n4,643\n10,011\xa0\n(3) 자본변동표\n반\xa0\xa0 기\xa0\xa0 자\xa0\xa0 본\xa0\xa0 변\xa0\xa0 동\xa0\xa0 표\n제65기 2분기 :\xa0 2020년 01월 01일부터 2020년 06월 30일까지\n제64기 2분기 :\xa0 2019년 01월 01일부터 2019년 06월 30일까지\n제64기\xa0 :\xa0 2019년 01월 01일부터 2019년 12월 31일까지\n제63기\xa0 :\xa0 2018년 01월 01일부터 2018년 12월 31일까지\n삼성생명보험주식회사\n(단위 : 백만원)\n과\xa0 목\n자본금\n자본잉여금\n자본조정\n기타포괄손익누계액\n이익잉여금\n총계\n2018.1.1 (전전기초)\n100,000\xa0\n6,131\xa0\n(2,110,369)\n17,100,637\xa0\n11,722,304\xa0\n26,818,703\xa0\nⅠ.당기총포괄손익\n\xa0\xa0 1.당기순이익\n-\n-\n-\n-\n1,797,774\n1,797,774\n\xa0\xa0 2.매도가능금융자산평가손익\n-\n-\n-\n(2,005,873)\n-\n(2,005,873)\n\xa0\xa0 3.만기보유금융자산평가손익\n-\n-\n-\n(15)\n-\n(15)\n\xa0\xa0 4.위험회피목적파생상품평가손익\n-\n-\n-\n244,937\n-\n244,937\n\xa0\xa0 5.관계기업의기타포괄손익지분\n-\n-\n-\n(30,735)\n-\n(30,735)\n\xa0\xa0 6.특별계정기타포괄손익\n-\n-\n-\n45,543\n-\n45,543\n\xa0\xa0 7.순확정급여부채재측정요소\n-\n-\n-\n(12,705)\n-\n(12,705)\nⅡ.자본에 직접 인식된 주주와의 거래\n\xa0\xa0 1.연차배당\n-\n-\n-\n-\n(359,150)\n(359,150)\n2018.12.31 (전전기말)\n100,000============\n6,131============\n(2,110,369)============\n15,341,789============\n13,160,928============\n26,498,479============\n2019.1.1 (전기초)\n100,000\xa0\n6,131\xa0\n(2,110,369)\n15,341,789\xa0\n13,160,928\xa0\n26,498,479\xa0\nⅠ.반기총포괄손익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0\xa0 1.반기순이익\n\u3000\n\u3000\n\u3000\n\u3000\n656,669\xa0\n656,669\xa0\n\xa0\xa0 2.매도가능금융자산평가손익\n\u3000\n\u3000\n\u3000\n4,710,265\xa0\n\u3000\n4,710,265\xa0\n\xa0\xa0 3.위험회피목적파생상품평가손익\n\u3000\n\u3000\n\u3000\n17,823\xa0\n\u3000\n17,823\xa0\n\xa0\xa0 4.관계기업의기타포괄손익지분\n\u3000\n\u3000\n\u3000\n27,719\xa0\n\u3000\n27,719\xa0\n\xa0\xa0 5.특별계정기타포괄손익\n\u3000\n\u3000\n\u3000\n102,137\xa0\n\u3000\n102,137\xa0\n\xa0\xa0 6.순확정급여부채재측정요소\n\u3000\n\u3000\n\u3000\n(936)\n\u3000\n(936)\nⅡ.자본에 직접 인식된 주주와의 거래\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0\xa0 1.연차배당\n\u3000\n\u3000\n\u3000\n\u3000\n(475,873)\n(475,873)\n2019.6.30 (전반기말)\n100,000 ============\n6,131 ============\n(2,110,369)============\n20,198,797 ============\n13,341,724 ============\n31,536,283 ============\n2020.1.1 (당기초)\n100,000\n6,131\n(2,110,369)\n21,570,927\n13,518,860\n33,085,549\nⅠ.반기총포괄손익\n-\n-\n-\n-\n-\n-\n\xa0\xa0 1.반기순이익\n-\n-\n-\n-\n618,001\n618,001\n\xa0\xa0 2.매도가능금융자산평가손익\n-\n-\n-\n(126,665)\n-\n(126,665)\n\xa0\xa0 3.위험회피목적파생상품평가손익\n-\n-\n-\n(3,731)\n-\n(3,731)\n\xa0\xa0 4.관계기업의기타포괄손익지분\n-\n-\n-\n11,591\n-\n11,591\n\xa0\xa0 5.특별계정기타포괄손익\n-\n-\n-\n58,804\n-\n58,804\n\xa0\xa0 6.순확정급여부채재측정요소\n-\n-\n-\n(1,676)\n-\n(1,676)\nⅡ.자본에 직접 인식된 주주와의 거래\n-\n-\n-\n-\n-\n-\n\xa0\xa0 1.연차배당\n-\n-\n-\n-\n(475,873)\n(475,873)\n2020.6.30 (당반기말)\n100,000\n6,131\n(2,110,369)\n21,509,250\n13,660,988\n33,166,000\n(4) 현금흐름표\n반\xa0\xa0 기\xa0\xa0 현\xa0\xa0 금\xa0\xa0 흐\xa0\xa0 름\xa0\xa0 표\n제65기 2분기 :\xa0 2020년 01월 01일부터 2020년 06월 30일까지\n제64기 2분기 :\xa0 2019년 01월 01일부터 2019년 06월 30일까지\n제64기\xa0 :\xa0 2019년 01월 01일부터 2019년 12월 31일까지\n제63기\xa0 :\xa0 2018년 01월 01일부터 2018년 12월 31일까지\n삼성생명보험주식회사\n(단위 : 백만원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 목\n제 65 (당) 2분기\n제 64 (전) 2분기\n제 64 (전) 기\n제 63 (전전) 기\nⅠ.영업활동으로부터의 현금흐름\n\u3000\n(1,529,591)\n\u3000\n3,318,274\xa0\n\u3000\n8,946,225\n\u3000\n3,110,417\xa0\n\xa01. 영업활동에서 창출된 현금흐름\n(5,133,194)\n478,160\xa0\n\u3000\n3,155,903\n\u3000\n(3,182,027)\n\u3000\n\xa0\xa0 가. 반기순이익\n618,001\n656,669\xa0\n\u3000\n833,805\n\u3000\n1,797,774\xa0\n\u3000\n\xa0\xa0 나. 손익조정사항\n638,907\n\u3000\n(146,495)\n\u3000\n484,323\n\u3000\n119,084\xa0\n\u3000\n\xa0\xa0 다. 자산ㆍ부채의 증감\n(6,390,102)\n\u3000\n(32,014)\n\u3000\n1,837,775\n\u3000\n(5,098,885)\n\u3000\n\xa02. 이자의 수취\n2,885,418\n\u3000\n2,818,163\xa0\n\u3000\n5,649,573\n\u3000\n5,725,073\xa0\n\u3000\n\xa03. 이자의 지급\n(6,159)\n\u3000\n(4,399)\n\u3000\n(10,670)\n\u3000\n(7,135)\n\u3000\n\xa04. 배당금 수입\n491,259\n\u3000\n542,824\xa0\n\u3000\n956,701\n\u3000\n965,533\xa0\n\u3000\n\xa05. 법인세부담액\n233,085\n\u3000\n(516,474)\n\u3000\n(805,282)\n\u3000\n(391,027)\n\u3000\nⅡ. 투자활동으로부터의 현금흐름\n\u3000\n(1,213,951)\n\u3000\n(3,371,492)\n\u3000\n(6,083,965)\n\u3000\n(3,394,565)\n\xa0 1. 매도가능금융자산의 처분\n7,565,380\n3,717,250\xa0\n\u3000\n8,282,717\n\u3000\n10,270,980\xa0\n\u3000\n\xa0 2. 매도가능금융자산의 취득\n(8,817,143)\n\u3000\n(7,566,929)\n\u3000\n(14,593,878)\n\u3000\n(14,435,116)\n\u3000\n\xa0 3. 만기보유금융자산의 증감\n-\n\u3000\n-\xa0\n\u3000\n17,207\xa0\n\u3000\n\xa0 4. 위험회피목적파생상품자산의 정산\n(124,385)\n(14,910)\n\u3000\n(205,019)\n\u3000\n27,189\xa0\n\u3000\n\xa0 5. 관계ㆍ종속기업투자주식의 처분\n106,358\n1,000,520\xa0\n\u3000\n1,486,265\n\u3000\n1,110,022\xa0\n\u3000\n\xa0 6. 관계ㆍ종속기업투자주식의 배당금\n236,546\n280,867\xa0\n\u3000\n368,345\n\u3000\n250,697\xa0\n\u3000\n\xa0 7. 관계ㆍ종속기업투자주식의 취득\n(406,830)\n(946,676)\n\u3000\n(1,620,969)\n\u3000\n(1,364,302)\n\u3000\n\xa0 8. 투자부동산 및 유형자산의 취득\n(23,002)\n(40,668)\n\u3000\n(82,006)\n\u3000\n(135,885)\n\u3000\n\xa0 9. 투자부동산 및 유형자산의 처분\n676\n233,287\n\u3000\n334,962\n\u3000\n2,768\xa0\n\u3000\n\xa0 10. 매각예정자산의 처분\n271,500\n\u3000\n-\n959,079\n\u3000\n\xa0 11. 무형자산의 취득\n(23,444)\n(36,142)\n\u3000\n(58,297)\n\u3000\n(97,631)\n\u3000\n\xa0 12. 무형자산의 처분\n393\n1,909\xa0\n\u3000\n3,915\n\u3000\n427\xa0\n\u3000\n\xa0 13. 기타\n-\n\u3000\nⅢ. 재무활동으로부터의 현금흐름\n(521,223)\n\u3000\n(512,430)\n\u3000\n(562,646)\n\u3000\n(401,483)\n\xa0\xa0 1. 배당금 지급 등\n(521,223)\n(512,430)\n\u3000\n(562,646)\n\u3000\n(401,483)\nⅣ. 현금및현금성자산의 순증감\n(3,264,765)\n\u3000\n(565,648)\n2,299,614\n\u3000\n(685,631)\nⅤ. 기초의 현금및현금성자산\n4,395,740\n\u3000\n2,095,482\xa0\n2,095,482\n\u3000\n2,780,299\xa0\nⅥ. 외화표시 현금 및 현금성자산에 대한\xa0 \xa0\xa0 환율변동효과\n98\n\u3000\n634\xa0\n644\n\u3000\n814\xa0\nⅦ. (반)기말의 현금및현금성자산\n1,131,073\n\u3000\n1,530,468 \n4,395,740\n\u3000\n2,095,482 \n(5) 이익잉여금처분계산서\n이익잉여금처분계산서\n제\xa0 64\xa0 기\n2019년\n1월\n1일\n부터\n제\xa0 63\xa0 기\n2018년\n1월\n1일\n부터\n2019년\n12월\n31일\n까지\n2018년\n12월\n31일\n까지\n처분확정일\n2020년\n3월\n19일\n처분확정일\n2019년\n3월\n21일\n삼성생명보험주식회사\n(단위 : 백만원)\n과\xa0\xa0 목\n제\xa0\xa0 64\xa0 \xa0 기\n제\xa0\xa0 63\xa0\xa0 기\nⅠ. 미처분이익잉여금\n13,007,960\n12,676,719\n1. 전기이월미처분이익잉여금\n12,174,156\n10,878,945\n2. 당기순이익\n833,804\n1,797,774\nⅡ. 이익잉여금처분액\n494,320\n502,563\n1. 배\xa0 \xa0 당\xa0 \xa0 금\n475,873\n475,873\n가. 현 금 배 당\xa0 \xa0\xa0 [주당배당금(률) \xa0 \xa0 \xa0\xa0\xa064기 :\xa02,650원(530%)\xa0\xa0 \xa0 \xa0\xa0 63기 : 2,650원(530%)]\n475,873\n475,873\n\xa0\xa0 2. 대손준비금\n18,447\n26,690\nⅢ. 차기이월미처분이익잉여금\n12,513,641\n12,174,156\n- 당반기말 이익잉여금처분 내역은 존재하지 않습니다.\n']"
